Shalini Sharp, EVP, Finance at Ultragenyx Pharmaceutical Inc. (RARE), sold 375 shares at $87.99 ($33K) on 2020-10-14, disclosed to the SEC on 2020-10-16.
Open-market sale of $33k RARE by EVP, Finance. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| RARE | SELL | 2020-06-05 | $1.9M | — | Filing → |
| RARE | SELL | 2020-05-20 | $4.3M | — | Filing → |
| RARE | SELL | 2019-04-17 | $133K | — | Filing → |